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Photodynamic therapy is a non-invasive option for eliminating superficial 
tumors and to control infections. However, despite some protocols are already 
approved for the clinic, PDT applications could be much broader if some of its 
main hindrances were overcome. For instance, the most efficient photosensitizers 
are hydrophobic, so if one injects them intravenously they tend to aggregate and 
to be internalized by phagocytes in the blood, impairing the delivery to the target 
site. In addition, visible light has a limited penetration in tissues, therefore the main 
applications of PDT are limited to superficial tumors unless an invasive procedure is 
used for the light to reach deeper sites. Another setback is the hypoxia that com-
monly happens in tumors, hindering the full potential of PDT as it depends on a 
constant oxygen supply. In this chapter the reader will find some strategies based 
on Nanotechnology to overcome these and other obstacles for PDT to reach its full 
clinical potential, i.e. hypoxia-reverting protocols, X-ray-driven PDT, Cherenkov 
radiation-driven PDT, and active tumor-targeting.
Keywords: photodynamic therapy, nanotechnology, active targeting, X-PDT, 
CR-PDT
1. Introduction
Nanotechnology consists on the development of materials with dimensions 
usually between 1 and 100 nm, where the properties of matter are significantly 
different than their bulk counterparts, and can be tuned to the desired application. 
These novel chemical and physical properties are usually derived from quantum 
effects and from the drastically increased surface-to-volume ratio. Furthermore, 
since many biological structures, i.e. proteins, organelles, viruses, etc., can be found 
within the nanometric scale, synthetic nanostructures have easy access to biological 
systems.
Although Nanotechnology started purely as a physical and materials science, 
soon the medical properties of nanomaterials became evident, and the new era of 
nanomedicine and nanopharmacy started. Nanomaterials are now recognized as 
excellent therapeutic and diagnostic tools, and thousands of novel compounds and 
nanostructures are developed every year, for the most diverse applications.
As you will see in this chapter, Nanotechnology can help practitioners to over-
come several hindrances of photodynamic therapy that have so far prevented this 
approach from reaching a broader clinical success. Over the last decade, nano-
structures have been applied as drug delivery platforms for PDT, and as strategies 
to enhance the efficiency of photosensitizers in generating ROS upon irradiation. 
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The nanoparticles can be organic or inorganic, can assume a multitude of shapes 
and sizes within the nanoscale, can act as photosensitizers themselves or as energy 
transducers. Even further, nanocarriers prevent the complications that arise 
from the poor solubility of photosensitizers in aqueous media, and increase the 
tumor accumulation in order to preserve healthy tissues. We are going to discuss 
in details the most relevant data regarding the enhancement of PDT by the use of 
nanomaterials.
2. Nanotechnology in combination with PDT
2.1 Main hindrances of PDT
There is a plethora of photosensitizing compounds available, but the majority 
of them did not present the requirements for clinical trials, i.e. good solubility, 
target selectivity, sufficient light absorption on the desired wavelength, and low 
accumulation in distant sites, especially the skin [1]. One of the biggest hindrances 
of photosensitizers is their hydrophobicity and consequent tendency to aggregate 
in aqueous environments, making the intravenous administration difficult unless 
some kind of delivery system is used [2, 3]. Besides, it is desirable that the photosen-
sitizers accumulate preferentially in the target tissue rather than in healthy sites in 
order to avoid toxicity, therefore strategies of targeted delivery are often necessary 
to increase the therapeutic efficiency, and nanoparticle systems offer great advan-
tages in this regard [1].
Besides the tendency to aggregate when photosensitizers are injected intrave-
nously, they tend to be distributed to the whole body in a non-specific way, and 
to be taken up by plasma proteins or phagocytes, decreasing significantly the 
efficiency of PDT. To increase the specific delivery and avoid side effects, several 
carriers have been developed to take advantage of the enhanced permeation and 
retention (EPR) effect or to actively target tumors and enhance specific accumula-
tion, such as polymer and metal nanoparticles, micelles and liposomes, and mag-
netic nanoparticles. The EPR effect is caused by the leaky vasculature common to 
tumor tissues, due to the sinusoid capillaries and the fenestrated endothelial cells, 
plus the inefficient lymphatic drainage from tumor sites. The active targeting, on 
the other hand, is actually a plethora of strategies to increase specific tumor accu-
mulation of a drug or therapeutic compound [3].
Another obstacle for photodynamic therapy is the limited penetration of 
light, so it is used mostly for superficial tumors, or with the help of optic fibers 
introduced in the patient. Recently, researchers have been developing strategies to 
produce light inside of the body with the help of nanoparticle scintillators. These 
materials are able to convert external X-ray photons, which can reach deeper sites 
in the organism, into visible light photons that could excite a photosensitizer in a 
process called X-PDT. Another approach to excite photosensitizers with endogenous 
light is with Cherenkov radiation in a process referred as CR-PDT. Cherenkov radia-
tion is generated when a particle exceeds the speed of light in a defined medium, 
and is common with the decay of several medical radioactive isotopes [4].
Photosensitizers that absorb in the NIR region, such as indocyanine green 
(absorption around 800 nm) and aluminum sulfophthalocyanine (absorption 
around 790 nm), although being able to be used in deeper regions due to the deeper 
penetration of NIR light, tend to be less efficient in generating singlet oxygen than 
other photosensitizers that absorb in lower wavelengths. Upconversion nanopar-
ticles (UCNs) can overcome these limitations. The process where the absorption 
of multiple photons – usually two or three – from a given wavelength leads to the 
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emission of photons from a shorter wavelength is referred as photon upconversion. 
This can be used as a strategy to reach deeper tissues with longer wavelengths and 
excite photosensitizers that absorb in shorter wavelengths and would not be reach-
able by light otherwise [5].
UCNs usually consist in inorganic luminescent materials, usually made with 
lanthanide elements that absorb NIR light and emit UV-visible light that can be 
used to excite more efficient photosensitizers. Other than the possibility of exciting 
photosensitizers in deeper regions and prevent photobleaching, enhancing PDT 
efficacy, they can carry a plethora of hydrophobic photosensitizers, either loaded 
physically or chemically [6, 7].
2.2 Nanomaterials used for PDT enhancement
Nanostructured delivery systems for photosensitizers can provide some major 
advantages in PDT. The first one is regarding the increased quantity of dyes that 
can be delivered to the target cell due to the large surface-to-volume ratio, while 
the second one refers to the prevention of the premature release of the dyes before 
reaching the target, enhancing the specific accumulation in the target tissue and 
diminishing the side effects. The third is somehow related to the second, since 
the loaded dyes find few obstacles in the blood stream and acquire an amphiphilic 
character once conjugated with nanostructures, enhancing the tumor accumulation 
as well. Another advantage is the privileged accumulation of nanosized materials 
in tumor tissues due to the enhanced permeability and retention (EPR) effect. 
Finally, their surface can be functionalized with a plethora of groups, so that their 
biodistribution, pharmacokinetics, cell uptake and surface chemistry can be tuned 
according to the desired application [8]. Figure 1 summarizes the main advantages 
of nanotechnology combined with PDT.
Both biodegradable and non-biodegradable nanoparticles can be used to poten-
tiate photodynamic therapy (PDT). In the case of biodegradable nanoparticles 
Figure 1. 
The combination of nanoparticles with photosensitizers and its main advantages for tumor ablation.
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(generally polymers and lipid-based structures), the photosensitizers are trapped 
inside them and are released in a controlled manner, so that singlet oxygen can be 
generated due to the exposition to light. On the other hand, when non-biodegradable 
nanoparticles are used, usually the photosensitizers are adsorbed on their surface 
(either external or internal, in case of porous structures), and they do not need to be 
released completely to generate singlet oxygen [1].
Regarding biodegradable nanoparticles, many photosensitizers have been encap-
sulated with water-soluble polymers, such as meso-tetra(hydroxyphenyl) porphy-
rin, bacteriochlorophyll, verteporfin, various phthalocyanines, methylene blue, and 
hypericin. Their singlet oxygen efficiency depends much on the polymer. Poly lactic 
glycolic acid (PLGA), for instance, has demonstrated good results compared to 
other polymers, along with poly lactic acid (PLA) and poly ethylene glycol (PEG). 
The pharmacodynamics of different polymer nanoparticles may differ from one 
another, and so do their bioavailability, thus the PDT efficiency may be different 
according to the nature of the polymer [1].
Non-biodegradable nanoparticles are mostly metallic or ceramic-based (espe-
cially silica), but polyacrylamide was also reported as a photosensitizer nanocarrier. 
Nevertheless, solid silica nanoparticles present higher singlet oxygen yield than 
polyacrylamide nanoparticles, i.e. 2 to 3-fold more singlet oxygen production by 
silica nanoparticles loaded with methylene blue compared to their polyacrylamide 
counterparts [1].
Plasmonic materials, a very important class of non-biodegradable nanomaterials, 
have proven to act as photosensitizers in the right conditions, and if they have photo-
sensitizers attached to their surface, they can enhance the photodynamic efficiency 
of the dye. It was observed that semiconductor nanoparticles that present the suitable 
energy gap can be used as photosensitizers and can also be conjugated with other 
organic dyes. In these conjugated materials, energy can be transferred from the 
excited nanoparticles to the photosensitizers through a FRET mechanism [5].
Gold and silver nanoparticles are more stable and present higher extinction 
coefficients than organic dyes, but if one desires to use them to generate singlet 
oxygen, O2 molecules must be adsorbed on their surface in order to provide a 
rapid energy transfer between the two. Furthermore, the energy transfer from the 
nanoparticles to the adsorbed oxygen molecules is more efficient in low-energy 
surface states of metal nanoparticles rather than the high-energy states. When these 
conditions are fulfilled, it is believed that the PDT antitumor efficiency can be up to 
10 times that of chemotherapeutics like doxorubicin [5].
Gold nanorods have been developed by different authors in order to carry phtha-
locyanines via adsorption onto the nanoparticle surface, either chemically with a 
thiol group or via electrostatic interaction. The formation of a phthalocyanine layer 
covering the nanoparticle prevents the aggregation of the hydrophobic photosensi-
tizer and enhances the photodynamic activity [2, 9].
Camerin and collaborators compared the efficacy of a phthalocyanine in its 
free form and conjugated with gold nanoparticles in ablating B78H1 amelanotic 
melanoma tumors in mice. The results showed that the accumulation of photo-
sensitizer in the tumor is enhanced when they are bound to the nanoparticles, 
and as a consequence, the damage was significantly more intense and the tumor 
growth was significantly slower than the tumors treated with the free phthalo-
cyanines [2].
Several cases of enhancement of the photosensitizer efficiency by plasmonic 
nanoparticles (due to a strong energy transfer and the prevention of photobleaching) 
have been reported in the literature, with various photosensitizers and nanoparticle 
morphologies and materials [9–13]. One interesting example was demonstrated 
by [14], because the PDT efficiency of the photosensitizer conjugated with gold 
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nanoparticles was comparable to the free photosensitizer, but the hyperthermal 
effect contributed to a more intense cytotoxicity against the tumor cells.
The material and the morphology of the plasmonic nanoparticles influence on 
the extinction coefficients and, consequently, on the energy transfer efficiency. 
Gold nanourchins, for instance, present an intense extinction coefficient at 940 nm, 
which is within the therapeutic window, and the singlet oxygen production was 
intense and sufficed to eliminate cancer HeLa cells while preserving normal 
NIH-3 T3 fibroblasts. Gold bipyramids can be efficient singlet oxygen generators if 
the wavelength used overlaps with the surface plasmon resonance peak, even more 
efficient than methylene blue. Silver and gold nanocubes are unable to generate 
singlet oxygen, while in the form of nanoprisms the opposite occurs [5].
This dependence on the morphology can be explained by theoretical calculations 
showing that O2 can be adsorbed on Au(111), Ag(111), Au(110), Ag(110), Au(100), 
and Ag(100) surfaces, but on Au(111), Au(100), and Ag(111) surfaces oxygen can 
remain in molecular form and be excited to its singlet state, whereas on the other 
surfaces it dissociates into its atomic form. This can only be altered when some 
defects are present in the crystalline structure [5].
Quantum dots are other promising materials for photodynamic therapy. 
Graphene quantum dots, for example, reduced tumor cell viability to 20% in a 
1.8 μM concentration, compared to 35% cell viability when the same concentration 
of PpIX was used. Similar results were obtained for ZnO quantum dots irradiated 
with blue light [5].
Silica is also widely used as a nanomaterial because it is non-toxic and optically 
transparent, and their surface chemical functionalization is easily achieved due to 
the presence of several hydroxyl groups on its surface. When it comes to PDT, silica 
can act as a carrier of photosensitizers, protecting them from enzymatic degrada-
tion and enhancing their permeation in tumors [5]. Figure 2 shows some of the 
most important nanomaterials used in combination with PDT.
2.3 Recent advances in X-PDT
X-ray driven PDT makes use of scintillating materials and/or radiosensitizers  
(Figure 3). High-Z elements, for instance, have inner shell electrons which are 
very efficient in capturing X-ray photons and converting them into relaxed 
electrons and visible light photons. Thus, the most common scintillators are 
nanoparticles of high-Z elements doped with rare earth elements, and present 
Figure 2. 
Some of the various morphologies and types of nanoparticles used in combination with PDT.
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useful properties for medical imaging and high-energy physics. The materials 
can be designed as films, coordination compounds, vitroceramics, metal-organic 
frameworks (MOFs), and hybrid organic-inorganic materials, and characteristics 
such as nanometric size, defects, coatings and media interaction influence on their 
scintillation properties [4].
Nanoscintillators can be basically divided in doped and semi-conductors scintil-
lators. Lantanides are the most explored as doped scintillators due to their high 
density, high-Z, and significant intensity of luminescence, while semiconductor 
scintillators are mostly composed of porous Si, Si nanocrystals, ZnO, CdSe, CdS, 
PbS, and CuBr [4].
The efficiency of X-PDT is largely affected by the intensity of X-Ray lumi-
nescence, the singlet oxygen yield of the photosensitizer, and the way the photo-
sensitizer is bound to the nanomaterial (either by covalent bonding, electrostatic 
interactions, or by pore loading). Furthermore, part of the tumor ablation might be 
due to the generation of UV photons during the scintillation process, apart from the 
photodynamic effect. The radiosensitization effect must also be considered, since 
high-Z materials generate ROS whenever their electrons are excited by X-rays into 
states above the conduction band edge, consequently producing electron hole pairs 
that interact with water producing hydroxyl radicals, and the electrons generate 
superoxide and peroxide radicals when they react with O2. Those ROS increase the 
cytotoxicity of the materials under X-ray irradiation [4].
Nanoscale metal-organic frameworks (nMOFs) consist of the self-assembly 
of metal ions or clusters and bridging ligands, usually organic polydentate. These 
materials are used as a means to put scintillators and photosensitizers closer to each 
other, enhancing the singlet oxygen generation efficiency [4].
Nanosized MOFs are usually biodegradable, offering a significant advantage 
over other nanomaterials, depending on the desired application. They encompass 
a virtually infinite possibility of structures due to the large availability amount of 
organic linkers and metallic parts; however, it is of utmost importance to select 
the components in accordance with the desired application in order to optimize 
the results. In the medical field, the use of MOFs is still in the prelude, since more 
pharmacokinetic, pharmacodynamics and biological characterization studies must 
be performed so that these materials reach clinical trials [15].
Regarding the use of lanthanides as scintillators, Dou et al. synthesized UCNs 
(NaYF4:Yb,Tm) covalently conjugated with chlorin e6 to prevent the premature 
Figure 3. 
Deeper penetration of X-rays and it use for X-PDT. The red circles symbolize singlet oxygen generated by the 
interaction of the excited photosensitizer and molecular oxygen.
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release of the photosensitizer and tested them in vitro. The nanoparticles were more 
efficient than the free photosensitizer even at low concentrations, and the efficacy 
can be fine-tuned by adjusting the dose of Ce6-UCNs and the laser power [7]. On 
the other hand, non-lanthanide materials such as SiC/SiOx core/shell nanowires 
functionalized with azide groups and porphyrin derivatives were tested for X-PDT 
and demonstrated significant efficacy. This material showed to be non-cytotoxic in 
the dark, and emits fluorescence at 545 nm when irradiated with X-rays, exciting 
the porphyrin derivative in the process [4].
Another example of experimental X-PDT was performed by Sivasubramanian 
et al. using BaFBr:Eu2+ nanoparticles loaded with porphyrins. When irradiated 
with 3 Gy of X-rays, the nanoparticles generated luminescence that matched the 
excitation wavelengths of the photosensitizer, leading to photodynamic effect 
that damaged the DNA, the mitochondria, and generated intense oxidative stress, 
significantly killing prostate cancer cells in vitro [16].
One of the main concerns about X-PDT is the radiation dose that needs to be 
applied to the patients. In order to diminish the amount of radiation that the patient 
must be exposed to, some scintillators that present persistent luminescence upon 
irradiation, rather than fluorescence, are the option. Fluorescence is a phenom-
enon that lasts for a few nanoseconds, while persistent luminescence can persist 
for minutes to hours after the excitation, therefore the required dose of radiation 
for excitation can be significantly decreased. There are evidences that persistent 
luminescence decreases the rate of oxygen consumption during PDT and may avoid 
the undesired hypoxia that hinders the photodynamic efficacy [4].
2.4 Recent advances in CR-PDT
Cherenkov radiation-driven PDT, symbolized in Figure 4, takes advantage of 
the fact that most radiopharmaceuticals accumulate in tumors in a selective manner, 
therefore the photodynamic ablation may occur in a more localized way. However, 
the generation of Cherenkov radiation occurs in low fluence rates, usually not 
enough to enable a good photodynamic efficiency [4].
There is a significant advantage, though, of CR-PDT over X-PDT, which is 
the possibility of targeting multiple metastases easier than with external X-rays. 
Figure 4. 
Cherenkov radiation being generated after radionuclide decay, and its ability to excite photosensitizers in order 
to perform PDT. The red circles symbolize singlet oxygen.
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Furthermore, even if the photons generated by the radionuclides are in much lower 
number than external irradiation (and possibly insufficient to exert significant 
phototoxicity), it is likely that the damage induced directly by the radionuclides 
contribute synergistically for the success of tumor ablation with CR-PDT [17].
An example of experimental CR-PDT was performed by Kamkaew et al. The 
authors encapsulated the radionuclide 89Zr with chlorin e6 into a mesoporous 
silica nanoparticle. The zirconium Cherenkov radiation emission is mostly in the 
UV region, but there is a significant emission in the blue region around 400 nm, 
corresponding to one of the absorption peaks of chlorin e6. The results in vitro 
showed high levels of DNA damage when the photosensitizer is present compared 
to the radionuclide alone, while in vivo results showed complete tumor remission 
after 14 days, even with a sublethal radiation dose of 15 MBq. However, a significant 
amount of radioactive nanoparticles were found in the liver after 14 days, so strate-
gies to avoid toxicity to health tissues must be applied [18].
Nevertheless, much progress is yet to be made before X-PDT and CR-PDT 
become official clinic protocols, despite all the successful results that have been 
obtained so far. The mechanisms of cell death by the combination of radiotherapy 
and PDT must be fully understood, and the materials used as scintillators must be 
fully characterized and optimized [4].
2.5 Hypoxia-reverting strategies
PDT efficacy in tumors is limited by the oxygen supply to the tumors, which 
tends to be reduced due to deteriorated microcirculation, especially in the tumor 
center. Since PDT consumes oxygen, it increases even further the local hypoxia, 
preventing the technique to reach its full potential. Therefore, some strategies to 
increase the availability of oxygen to the tumors while PDT is occurring have been 
developed in order to increase the tumor ablation [3]. Cheng and co-workers, for 
instance, loaded photosensitizers that are activated at 780 nm into perfluorocarbon 
nanodroplets enriched with oxygen with average size of 200 nm. The use of the 
nanodroplets also increases the half-life of singlet oxygen, so the PDT efficiency is 
enhanced both in vitro and in vivo. With intravenous administration, the tumors 
were significantly ablated, but with intratumor administration the tumors were 
eliminated completely [19].
It was observed by Kim et al. that O2 can be efficiently produced via Fenton 
reaction in cancer tissues due to the abundancy of H2O2 derived from the tumor 
metabolism, especially when mesoporous silica nanoparticles are conjugated to 
manganese ferrite nanoparticles, which are classical Fenton catalysts, and loaded 
with chlorin e6. This system enabled a continuous PDT process by providing the 
tissue with the necessary amount of O2 via Fenton reaction, and could act as a con-
trast agent for magnetic resonance imaging, acting as a theranostic material [20].
In this regard, cerium oxide nanoparticles provide a good alternative for con-
verting hydrogen peroxide into molecular oxygen and water, even in the absence of 
light irradiation. They are, therefore, a smart strategy to provide the hypoxic tissues 
with oxygen to enhance PDT efficacy, as demonstrated by Jia et al. The authors used 
a mesoporous core-shell structure consisting of NaGdF4:Yb,Tm@NaGdF4 upconver-
sion nanoparticles coated with CeOx capable of converting NIR light into UV light, 
which activates cerium oxide to produce ROS. Since the nanoparticles have a hollow 
interior, they can also be used as a drug carrier for a combined chemotherapy, 
besides being very efficient in tumor ablation by PDT [21].
Although most of the oxygen-generating strategies make use of the excess of 
hydrogen peroxide caused by the intense metabolism of tumors, which can react 
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with iron cations generating O2 and hydroxyl radicals. There is a class of materials, 
however, that uses water as the source of oxygen, the so-called water-splitting 
materials, commonly used for solving energy and environmental problems. Since 
water is the major component of the organism, there is a virtually endless supply  
of oxygen to be used for PDT enhancement. Metal-free C3N4 decorated with 
carbon dots (in order to enhance the water-splitting upon irradiation with red 
light) was used by Zheng et al. as a water-splitting material. The nanocomposite 
was conjugated with the compound PpIx-PEG-RGD, consisting of the photosen-
sitizer protoporphyrin IX with polyethylene glycol and the peptide sequence RGD 
(arginine, glycine, and asparagine) for active tumor targeting and photodynamic 
therapy. Under 630 nm irradiation, there was an increased O2 concentration and 
singlet oxygen production, enabling a significant cell killing without the occurrence 
of hypoxia [22].
Red blood cells (RBCs) can be used as photosensitizer and oxygen carriers at the 
same time in order to increase the efficacy of PDT in hypoxic situations. Wang et al., 
for example, coupled the photosensitizer Rose Bengal and a hypoxic probe on the 
surface of RBCs. Upon low levels of oxygen, the hypoxic probe can switch to an active 
state and undergo an orthogonal near-infrared upconversion, resulting in the release 
of O2 from the oxygenated hemoglobin when 980 nm light is applied. The photody-
namic process is, thus, kept for longer and results in a better tumor ablation [3].
Oh the opposite side of the previous strategies, a protocol has been developed 
in order not to avoid the hypoxia in the tumors, but to use it to potentiate chemo-
therapy after PDT has been performed. This is possible with the use of hypoxia-
activated prodrugs such as triapazamine or apaziquone. He and collaborators used 
nanoscale metal-organic frameworks (NMOFs) as porous nanocarriers of pho-
tosensitizers and hypoxia-activated chemotherapeutics. Both in vitro and in vivo 
results indicate an on-demand release behavior of the nanoparticles and an intense 
tumor ablation, therefore it consists on a promising antitumor strategy [23].
2.6  Tumor-targeting and specific delivery strategies for PDT using 
nanomaterials
One of the most common strategies of actively targeting specific organs or 
tissues is by the use of antibodies. Stuchinskaya and collaborators combined the 
versatility of gold nanoparticles with a hydrophobic photosensitizer (zinc phtha-
locyanine derivative), preventing its aggregation before reaching the target, and 
decorated the nanoparticle with tumor-specific antibodies (anti-HER2 for breast 
cancer) by covalent bonds formed with the coating layer of polyethylene glycol. 
There was a high efficiency in singlet oxygen generation in cancer cells after a 
selective targeting [24].
Active targeting can also make use of membrane proteins that are overexpressed 
in tumor cells, i.e. some integrins and neuropilin-1. By coupling ligands like RGD 
(a tripeptide composed of arginine, glycine, and aspartate), biotin, and folic acid 
to nanocarriers, the tumor accumulation is significantly enhanced [3]. Organelle 
targeting is also an option, especially when it comes to mitochondria. Several lines 
of evidence show that targeting the mitochondria for PDT avoids drug-resistance by 
tumor cells via a decreased level of intracellular ATP (the drug resistance phenotype 
in tumor cells is often associated with overexpressed ATP-driven transmembrane 
efflux pumps), besides the fact that damage to the mitochondria often leads to cell 
death [25]. Targeting the lysosomes can be additionally useful because the leakage 
of protons and hydrolases into the cytoplasm can damage inner structures and lead 
to cell death [3].
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Another reason that makes organelle-targeting important is the short action 
range of singlet oxygen (no more than 20 nm), so a localized photosensitizer 
excitation is required. Hou et al. developed a Fe3O4@Dex-TPP nanoparticles that 
enhance the oxygen concentration in tumor cells via Fenton reaction, target the 
mitochondria (via the triphenylphosphine group, TPP), and are able to be imaged 
by magnetic resonance imaging due to the magnetic behavior of Fe3O4. This system 
was loaded with the photosensitizer protoporphyrin IX and grafted with a reduced 
glutathione-responsive moiety. Upon internalization, Fe2+ and Fe3+ ions are liber-
ated from the Fe3O4 core and diffuse into the cytoplasm, then oxygen is produced 
by Fenton reaction (Fe2+ reacting with the excess of H2O2 producing O2 and 
hydroxyl radical (•OH). This allows the PDT process to keep occurring, enhancing 
the therapeutic efficacy [25].
One of the strategies for specific delivery is the development of pH-sensitive 
materials that make use of the mild acidity environment found in tumors (around 
6.5 to 7.2). Ai and co-workers developed upconversion nanoparticles with a low-pH 
insertion peptide that in acidic environments allow the insertion of the nanopar-
ticles into the plasma membrane. They observed a large accumulation in the tumor 
tissue compared to healthy tissues [26].
Calcium phosphate is a biocompatible and biodegradable material, as it is the 
main component of hard tissues such as bones and teeth. It is sensitive to pH, main-
taining its stable structure in physiological pH and dissolves in acidic environments, 
therefore it can be useful for controlled delivery to tumors. Another advantage relies 
on the fact that, once inside the cells, calcium phosphate nanoparticles dissolve and 
liberate calcium ions across lysosomal membranes, impairing the osmotic pressure 
of the cell and leading it to necrosis [27].
Liu et al. fabricated calcium phosphate-encapsulated core-shell structured 
nanoparticles (UCNPs-Ce6@SiO2@Calcium phosphate-Doxorubicin), characteris-
tic for being biodegradable, biocompatible, pH-sensitive (which enables the libera-
tion of the chemotherapeutic in the tissue), and provides therapeutic efficiency by 
PDT upon irradiation with 808 nm due to the presence of Chlorin e6 in its structure. 
Finally, due to the presence of rare earth elements, it can be used as an imaging tool 
for diagnostic purposes [27].
Another strategy is the development of nanomaterials that can be degraded 
by enzymes that are overexpressed in tumors, such as matrix metalloproteinases 
(MMPs) and hyaluronidase. One good example is the nanomaterial developed by Li 
et al. [28], which consisted of hyaluronic acid nanoparticles conjugated with chlorin 
e6 that disassemble in the presence of hyalurinodase and liberate the photosensi-
tizer. This way, they can act as theranostic materials, meaning they can use as diag-
nostic tools and therapeutic agents. Another example was the MMP2-responsive 
chimeric peptide nanoparticles coupled with protoporphyrin-IX, which turn from a 
sphere into large fibers when MMP-2 is present, and this sphere-to-fiber transition 
contributes to the augmented tumor retention of the nanoparticles [29].
Dai et al. developed a peptide nanoparticle coupled with protoporphyrin-IX 
(PpIX-Ahx-K8(DMA)-PLGVR-PEG8) responsive to both pH and enzyme. This 
nanoparticle assumes a spherical shape while in circulation and avoids nonspecific 
uptake, and when in tumor environments they undergo a charge reversal and cleav-
age of the PLGVR sequence by MMP-2. Simultaneously, the DMA group is detached 
because of the low pH. This logic worked to enhance even more the specific uptake 
by tumor tissues [23].
A very intricate nanosystem combining tumor-targeted PDT with antiangio-
genesis therapy and reduced glutathione (GSH) was developed by Min et al.. It 
consisted on a porphyrinic zirconium-metal-organic framework nanoparticle that 
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can act simultaneously as a photosensitizer and a carrier of the vascular endothelial 
growth factor receptor 2 (VEGFR2) inhibitor apatinib. MnO2 covers the nanopar-
ticle core in order to consume the intratumoral GSH, and the whole system is 
decorated with a camouflage made of a tumor cell membrane. The tumor specificity 
was much enhanced, and so was the ablative efficiency of the combined treatment 
provided by this nanomaterial [30].
In addition to the previous strategies, some researchers have developed 
nanoparticles that are activated by near-infrared light for selective photodynamic 
therapy, protecting healthy tissues like the skin. The mechanism of action of 
these systems is based on the blockage of photodynamic action from the photo-
sensitizer by a co-loaded NIR dye via a fluorescence resonance energy transfer 
(FRET) effect. The photosensitizer action is recovered once the NIR dye is 
photobleached by NIR light irradiation in the specific site. Dong et al. developed 
CaCO3-PDA-PEG hollow and porous nanoparticles loaded with chlorin e6 for 
this purpose, and observed that they are degraded in acidic environments such 
as tumors, liberating the photosensitizer in a selective manner. The generation of 
singlet oxygen was enhanced in the acidic environment, and the photosensitizer 
was taken up more efficiently when administered within the nanoparticles, 
compared to the free photosensitizer and other formulations. It is worthy to men-
tion that when chlorin e6 is injected in a liposomal formulation, the mice present 
significant weight loss, probably due to an intrinsic toxicity, and this does not 
happen in the CaCO3-PDA-PEG formulation [31].
Jeong et al. tested human serum albumin nanoparticles loaded with chlorin e6 
in order to develop a more biocompatible system for enhanced PDT efficacy. The 
nanoparticles, with circa 88 nm in diameter, proved to be non-cytotoxic in the dark, 
but produced significant amounts of singlet oxygen upon irradiation with the appro-
priate wavelength. Remarkably, when injected in mice they provided a very specific 
tumor delivery compared with the free photosensitizer, and simultaneously provided 
a good imaging property die to the fluorescence of chlorin e6 [32].
PDT can be not only an adjuvant for chemotherapy, but also for immunotherapy, 
and nanotechnology can potentiate the results and enable the combination of the 
two therapies in one single approach. That is what was demonstrated by Xu et al. 
when they developed mesoporous silica nanoparticles made of amorphous silicon 
dioxide. The nanoparticles were relatively small (around 80 nm in diameter) in 
order to enhance the cell internalization and avoid side effects, and the pores 
were large (around 5–10 nm) in order to optimize the drug loading capacity. The 
nanoparticles were loaded with CpG oligodeoxynucleotide, which is a Toll-like 
receptor-9 agonist for immunotherapy, and chlorin e6. The authors observed an 
effective accumulation in tumors in vivo after intravenous injection, and the treat-
ment induced cell damage and the recruitment of dendritic cells. With the immune 
response elicited, there was a strong cancer vaccination effect, therefore tumors in 
distant sites can also be affected by the treatment [21].
Finally, a novel phenomenon has been calling the attention of researchers, 
namely aggregation-induced emission (AIE) of photosensitizers. Some fluoro-
phores are poor light emitters when they are in a single molecule state, but they 
become strong emitters when aggregated, enabling bioimaging with significant 
biocompatibility and photostability. Besides, they can generate singlet oxygen in 
the aggregated state, so they can act as efficient PDT agents. Liu and coworkers 
synthesized AIEsomes, which are lipid structures conjugated with compounds with 
AIE property, and tested their efficacy in vivo. Their compounds were biocompat-
ible, provided efficient bioimaging and loading efficiency, ultimately leading to a 
significant photodynamic effect [33].
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3. Conclusion
Photodynamic therapy has long proven to be an efficient way to eliminate 
tumors and control infections in a non-invasive way. PDT consists on the use 
of light-absorbent compounds named photosensitizers, which are able to excite 
O2 from its ground triplet state to its excited singlet state, or to generate reactive 
oxygen species whenever they are irradiated with an appropriate wavelength. Much 
success has been achieved so far, and some PDT protocols are already available for 
the treatment of tumors, skin infections and for dentistry applications.
Nevertheless, the full clinic potential of PDT is yet to be achieved, mainly due 
to some limitations of the technique, i.e. the lack solubility of photosensitizers 
and limited stability in aqueous media such as the blood and the biological tissues 
(which makes the administration to patients somewhat difficult), the limited 
penetration of light, especially in the visible spectrum (limiting most of the applica-
tions to superficial sites), and the hypoxia that is usually present in tumor tissues, 
especially the center, and is increased during photodynamic action (since PDT is 
intrinsically dependent on oxygen, hypoxia hinders the full therapeutic potential 
of PDT).
Nanotechnology offers potential solutions to these limitations due to the intrin-
sic properties of nanomaterials, derived mainly from quantum effects that appear 
in matter in the nanometric scale, and from the surface chemistry that is often 
optimized in nanomaterials. Nanoparticles can act as photosensitizers given the 
necessary conditions, or can potentiate the photodynamic properties of attached 
photosensitizers. Additionally, nanocarriers can be loaded with hydrophobic 
photosensitizers, avoiding their aggregation and enhancing their specific accumula-
tion in the target site. Finally, upconversion, scintillating and/or radiosensitizing 
nanomaterials enable the application of PDT in deep-seated tumors because they 
absorb wavelengths that reach deeper into the organism and emit visible light that 
can excite photosensitizers in the vicinity.
Nevertheless, some more studies must be performed in order to develop nano-
platforms that join the advantages of both Nanotechnology and Photodynamic 
Therapy, with good biocompatibility and with optimized clinical results. The 
potential, though, is strong for Nano-PDT to become various protocols for the most 
diverse medical applications.
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